829 related articles for article (PubMed ID: 30059372)
1. Stevens-Johnson Syndrome: A Challenging Diagnosis.
Davis WD; Schafer PA
Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus, pregnancy, and Stevens-Johnson syndrome.
Shilad A; Predanic M; Perni SC; Houlihan C; Principe D
Obstet Gynecol; 2005 May; 105(5 Pt 2):1254-6. PubMed ID: 15863600
[TBL] [Abstract][Full Text] [Related]
3. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Cartotto R
Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
[TBL] [Abstract][Full Text] [Related]
4. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
[TBL] [Abstract][Full Text] [Related]
5. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
[TBL] [Abstract][Full Text] [Related]
7. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
Oliveira A; Sanches M; Selores M
Acta Med Port; 2011 Dec; 24 Suppl 4():995-1002. PubMed ID: 22863510
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
[TBL] [Abstract][Full Text] [Related]
9. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
[TBL] [Abstract][Full Text] [Related]
11. Stevens-Johnson syndrome after erythromycin therapy while deployed at sea.
Williams DA
Mil Med; 2000 Aug; 165(8):636-7. PubMed ID: 10957862
[TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
[TBL] [Abstract][Full Text] [Related]
13. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
Boruah PK; Bolesta S; Shetty SM
Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
[TBL] [Abstract][Full Text] [Related]
14. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
[TBL] [Abstract][Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases.
Kara A; Devrim İ; Çağlar İ; Bayram N; Kundak S; Apa H; Altan EV
Turk J Pediatr; 2019; 61(4):538-543. PubMed ID: 31990471
[TBL] [Abstract][Full Text] [Related]
16. Toxic Epidermal Necrolysis: A Dermatologic Emergency and the Role of the Oral and Maxillofacial Surgeon.
Wolf B; Sadoff R; Nannini V
J Oral Maxillofac Surg; 2018 Aug; 76(8):1688-1694. PubMed ID: 29555183
[TBL] [Abstract][Full Text] [Related]
17. A Review of the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Woolum JA; Bailey AM; Baum RA; Metts EL
Adv Emerg Nurs J; 2019; 41(1):56-64. PubMed ID: 30702535
[TBL] [Abstract][Full Text] [Related]
18. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Pediatric Population: A Review.
Alerhand S; Cassella C; Koyfman A
Pediatr Emerg Care; 2016 Jul; 32(7):472-6. PubMed ID: 27380605
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy patient with Stevens-Johnson Syndrome presents to the Emergency Department: A case report.
Widmer S; Grossman M
Am J Emerg Med; 2018 Jul; 36(7):1325.e3-1325.e4. PubMed ID: 29743141
[TBL] [Abstract][Full Text] [Related]
20. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
Harr T; French LE
Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
